Breaking Explosion in Syrian Suburb Kills One, Wounds Several Two Arrested in Connection with Shooting Outside U.S. Consulate Trump Administration Buys Back Offshore Wind Leases for $1.2 Billion Jalapeño Peppers Linked to Multistate Salmonella Outbreak Traced to Mexican Grower and Distributor Veronica Burton Emerges as Key Player for Second-Year Golden State Valkyries

Thursday August 6, 2026

Reporter

LEADS BIOLABS CO., LTD.

4Articles Published

4Communities Covered

Published Articles

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals

18 hours ago

Press Release

Leads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases

Aug 4

Press Release

Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

Aug 3

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

Jul 30